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Introduction
The nitric oxide (NO) vasodilator system is important in the maintenance of vasoregulation and vascular health, and its function is a marker of cardiovascular risk. Endothelium-dependent flow-mediated dilatation (FMD) assesses conduit artery vasodilatory capacity predominately in response to the release of NO after a reactive hyperaemia stimulus (shear stress; Green et al. 2014) . Flow-mediated dilatation is dependent upon the vascular smooth muscle relaxation capacity, and this can be assessed by administering I.V. or sublingual glyceryl trinitrate (GTN, a nitric oxide donor); and assessing endothelium-independent flow-mediated dilatation or GTN-induced dilatation (Corretti et al. 2002; Maruhashi et al. 2013) . In the absence of any change in GTN-induced dilatation, any change in FMD is related to an impairment in the shear stress-mediated NO vasodilatory cascade rather than an impairment in vascular smooth muscle relaxation (Maruhashi et al. 2013 ; Lewis et al. 2014) . Together, the combined assessment of both FMD and GTN measures within subjects provide complementary information regarding the local change in vascular function in vivo (Celermajer et al. 1992) .
The effect of acute normobaric or hypobaric hypoxia on basal FMD and GTN-induced dilatation is unclear. Some studies have reported a significant decline following hypoxia (Bailey et al. 2013; Lewis et al. 2014) , whereas others report no change (Frick et al. 2006; Frøbert et al. 2008; Bailey et al. 2013) . These discrepancies are perhaps not surprising because studies are often confounded by pathologies such as metabolic syndrome (Frick et al. 2006) , chronic mountain sickness (Bailey et al. 2013 ) and cardiovascular disease (Frøbert et al. 2008) . Moreover, there are many methodological differences and limitations in these studies; e.g. different degrees of acute hypoxic exposure (5 min versus 1 h versus 3 days), different hypoxic stimuli (hypobaric hypoxia versus normobaric hypoxia; Frøbert et al. 2008; Lewis et al. 2014 ) and different population groups (native highlanders versus lowlanders; Bailey et al. 2013) .
By following international guidelines for the assessment of FMD and GTN-induced dilatation (Thijssen et al. 2011) , we recently documented a 14% decline in both FMD and GTN-induced dilatation after 3 days of hypobaric hypoxia (5050 m) in healthy individuals (Lewis et al. 2014) . In a follow-up study, we discovered that a substantial larger and sustained decline in FMD (ß28%) occurs as a result of 60 min of exposure to normobaric hypoxia [fraction of inspired oxygen (F I,O 2 ) 0.11; a hypoxic level simulating ß5000 m]. This marked reduction in FMD was abolished after blockade of sympathetic nerve activity (SNA; Lewis et al. 2014) , suggesting that elevated SNA in hypoxia might increase vasomotor tone (Fok et al. 2012) and constrain FMD via impaired smooth muscle relaxation. However, it is currently unknown whether vascular smooth muscle relaxation (GTN-induced dilatation) is impaired within 60 min following normobaric hypoxia. Furthermore, given the inverse relationship between graded reductions in inspired oxygen and elevations in muscle SNA (Rowell et al. 1989) , vascular dilator impairments during acute (<60 min) normobaric hypoxia might also be sensitive to the degree of hypoxia.
The primary purpose of this study was to examine the effect of acute (<60 min) exposure to mild [end-tidal partial pressure of oxygen (P ET,O 2 ) 75 mmHg; ß2000 m] and moderate (end-tidal P ET,O 2 = 50 mmHg; ß4600 m) isocapnic hypoxia on brachial FMD and GTN-induced dilatation. We hypothesized that FMD and GTN-induced dilatation would be impaired during mild hypoxia and more so during exposure to moderate levels of hypoxia. We intentionally chose this mild exposure as a comparable P O 2 to that encountered during commercial air travel (Smith et al. 2012) , during trekking and at ski vacation sites in North America. In view of the number of recent studies reporting that seated inactivity (e.g. 2-6 h; Thosar et al. 2014; Restaino et al. 2015) can alter shear patterns in the brachial artery, our secondary goal in order to help interpretation of our findings from our hypoxic studies, was to conduct a normoxic time-control study (post hoc) to quantify the effect of 30 min of supine rest on baseline brachial shear patterns and repeated FMD testing. Based on previously published guidelines (Corretti et al. 2002; Barton et al. 2011) , we reasoned that FMD and related haemodynamic variables would be unaltered after 30 min of normoxic supine rest.
Methods

Ethical approval
The study was approved by the Clinical Research Ethics Committee of The University of British Columbia (approval no. H11-03287) and conformed to the standards set by the Declaration of Helsinki (2013) except for registration in a database. All volunteers provided written and verbal informed consent.
Participants
Twelve healthy normotensive volunteers (seven men and five women; mean ± SD: age, 26 ± 6 years; body mass, 71 ± 12 kg; height, 176 ± 8 cm; and body mass index, 23 ± 3 kg m −2 ) participated in this randomized counterbalanced experiment. Participants were nonsmokers, had no previous history of cardiovascular, cerebrovascular or respiratory diseases and were not taking any medications, other than the contraceptive pill. Women were tested either during the the pill withdrawal/placebo phase or in the earlier follicular phase of the menstrual cycle of consecutive cycles. All experimental testing took place at the University of British Columbia (elevation 344 m).
Study design
Participants attended the laboratory on four occasions (one familiarization session and three experimental sessions). The experimental sessions were separated by >7 days, and each session commenced between 08.00 and 09.00 h. Experimental testing followed a minimum of 12 h abstinence from alcohol, caffeine and strenuous exercise, and an overnight fast. Experimental sessions 1 and 2 consisted of 20 min of supine rest, after which cardiorespiratory parameters were monitored for 5 min and the assessment of FMD was undertaken in normoxic conditions. Participants were then rapidly exposed to isocapnic hypoxia. After 30 min of isocapnic hypoxia exposure, cardiorespiratory measures and the assessment of FMD were repeated, and after 60 min of isocapnic hypoxia, GTN-induced dilatation was assessed. The level of isocapnic hypoxia experienced in each session was randomized and counterbalanced. Using end-tidal forcing, in the separate visits, the participant's P ET,O 2 was rapidly reduced to 75 (mild hypoxia) or 50 mmHg (moderate hypoxia) after the baseline assessments. End-tidal carbon dioxide (P ET,CO 2 ) was clamped at baseline values.
During experimental session 3, after 20 min of supine rest the assessment of GTN-induced dilatation was made in normoxic conditions, in eight of the 12 participants who completed experimental sessions 1 and 2. The assessment of GTN-induced dilatation was made on a separate day from the two hypoxic tests because of the half-life of GTN being ß4 h and the potential interference with other measures if conducted at normoxia in experimental sessions 1 or 2.
Experimental measurements and data analysis
Brachial artery vascular function. A 10 MHz multifrequency linear array probe attached to a high-resolution ultrasound machine (Terason 3000; Teratech, Burlington, MA, USA) was used to image the brachial artery in the right arm. Blood flow velocity was measured as the peak blood flow velocity of the Doppler shift, with the sample gate begin placed in the centre of the lumen.
Endothelium-dependent FMD. Flow-mediated dilatation was assessed according to international guidelines (Thijssen et al. 2011) . With the occluding cuff placed distal to the ultrasound probe, 1 min of brachial diameter and blood flow velocity recordings preceded forearm cuff inflation to 220 mmHg for 5 min. Brachial diameter and blood flow velocity recordings resumed 30 s before cuff deflation and continued for 3 min thereafter.
Endothelium-independent FMD (GTN). After 20 min of rest, brachial diameter and blood flow velocity recordings were made for 1 min before participants receiving a sublingual dose of GTN (400 μg spray, Nitrolingual, Sanofi Aventis, Québec, Canada). Brachial diameter and blood flow velocity recordings were made continuously for a 10 min period thereafter.
Custom-designed edge-detection and wall-tracking software, which is largely independent of investigator bias, was used for the analysis of FMD and GTN-induced dilatation (Woodman et al. 2001; Black et al. 2008; Thijssen et al. 2011) . This software provides continuous and simultaneous diameter and blood flow velocity at 30 Hz. From these synchronized diameter and velocity data, blood flow (the product of lumen cross-sectional area and Doppler velocity) and shear rate [SR (4 times velocity divided by diameter); Pyke et al. 2004; Pyke & Tschakovsky, 2007] are calculated at 30 Hz. This semi-automated software provides higher reproducibility of diameter measurements and reduces both observer error and bias, with a reported intra-observer coefficient of variation for FMD% of 6.7% (Woodman et al. 2001) . The FMD and GTN baseline diameter, along with pre-FMD blood flow and SR patterns, were calculated as the mean of data acquired across the minute preceding the cuff inflation period. The FMD and GTN peak diameter after cuff deflation or GTN administration was automatically detected according to an algorithm that identified the maximal diameter after the cuff deflation (3 min) or GTN administration (10 min), and FMD and GTN percentage change from baseline was calculated. The time to peak diameter (in seconds) was calculated from the point of cuff deflation or GTN administration to the detected peak diameter. The FMD SR area under the curve (SR AUC ) was calculated for the FMD stimulus up to peak diameter (Black et al. 2008) . Recent evidence has highlighted that FMD% can, in some circumstances, fail to consider the difference in baseline artery diameter following an intervention or between groups . Therefore, as outlined in detail elsewhere N. C. S. Lewis and others 2013), we adopted an allometric scaling approach to adjust for baseline diameter in the calculation of FMD. Baseline diameter, peak diameter and SR AUC were logarithmically transformed, and then a linear mixed model with repeated measures was performed in SPSS, where baseline diameter and SR AUC were selected as covariates. Covariate-adjusted means for diameter change were obtained from this SPSS model and then back-transformed, providing a baseline SR AUC -adjusted ratio of diameter peak /diameter base . These adjusted changes in diameter were then converted into an adjusted percentage change by subtracting a value of one and then multiplying by 100; this provides the 'corrected' FMD%. We also adjusted GTN-induced dilatation for changes in baseline diameter, following the same procedure. These results are presented as 'allometrically corrected' FMD% or GTN%.
Cardiorespiratory measures. Beat-to-beat blood pressure (BP) was measured by finger photoplethysmography (Finometer PRO; Finapress Medical Systems, Amsterdam, The Netherlands) and normalized to manual cuff measurements of the brachial artery. Stroke volume (SV) and cardiac output (CO) were calculated from the BP waveform obtained from the finger photoplethysmography using the Modelflow method, incorporating age, sex, height and weight (BeatScope 1.0 software; TNO TPD; Biomedical Instruments, Amsterdam, The Netherlands). Heart rate (HR) was measured via three-lead ECG (ML132; ADInstruments, Colorado Springs, CO, USA). All measures were monitored for 5 min before FMD assessment, where minute 4-5 was used as a representation of baseline values. Peripheral oxygen saturation (S aO 2 ; Pulse Oximeter MD300K1; Vacumed, Ventura, CA, USA) was measured immediately before the FMD assessment.
For measurement of P ET,CO 2 and P ET,O 2 , subjects breathed through a mouthpiece connected to a two-way non-rebreathing valve. Respired gas pressures were sampled at the mouth by securing a sample line connected to a calibrated online gas analyser (model ML206; AD Instruments, Colorado Springs, CO, USA) into the mouthpiece. Respiratory flow was measured at the mouth using a pneumotachograph (model HR 800L; HansRudolph, Shawnee, KS, USA). The P ET,CO 2 , P ET,O 2 and inspiratory and expiratory tidal volume were determined for each breath online using specifically designed software (LabView, Austin, TX, USA). The P ET,CO 2 and P ET,O 2 were controlled via an end-tidal forcing system (Tymko et al. 2015) . This system uses independent gas solenoid valves for oxygen, carbon dioxide and nitrogen and controls the volume of each gas delivered to the inspiratory reservoir through a mixing-andhumidification chamber. With use of feedback information regarding P ET,CO 2 , P ET,O 2 and inspiratory and expiratory tidal volume, the system prospectively targets the inspirate to bring end-tidal gas to the desired level. Gas control was fine-tuned using a feedback control and error reduction algorithm. Clamped P ET,CO 2 values were determined as the values measured during the last 5 min of normoxic measurements.
Normoxic time-control post hoc study Participants. Ten healthy normotensive volunteers (nine men and one woman; mean ± SD: age, 27 ± 2 years; body mass, 77 ± 8 kg; height, 180 ± 1 cm; and body mass index, 23 ± 2 kg m −2 ) participated in this study. All participant pre-experimental considerations were the same as described for the hypoxia studies.
Experimental design and methods. All participants were familiarized with the FMD protocol and attended the laboratory for one experimental session. Here, FMD was assessed in normoxic conditions before (FMD 1) and after 30 min of supine rest (FMD 2). All methodological and data analysis procedures were performed as outlined for the hypoxia studies.
Statistical analysis
All data were analysed using SPSS (version 21; IBM, Woking, UK) and expressed as means ± SD. Statistical significance was defined as P ࣘ 0.05 and distribution normality confirmed using repeated Shapiro-Wilk W tests.
Main hypoxia study. To examine the interaction between the experimental intervention (normoxia versus hypoxic stimuli) and the experimental conditions [P ET,O 2 75 mmHg (mild-hypoxia) trial versus P ET,O 2 50 mmHg (moderate-hypoxia) trial], a two-way repeated-measures ANOVA was used; to explore any significant interaction effect further, Student's two-tailed paired t tests were used to quantify the effect of the hypoxic stimuli on the measures of interest. For the assessment of GTN-induced dilatation and related variables, a one-way repeated-measures ANOVA was used to compare the trial difference between normoxia and the two hypoxic stimuli.
Normoxic time-control study. To examine the interaction between normoxic baseline and following 30 min of supine rest, Student's two-tailed paired t tests were used, unless stated otherwise.
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Values are expressed as means ± SD. Abbreviations: CO, cardiac output (n = 10); DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial blood pressure; P ET,CO 2 , end-tidal partial pressure of carbon dioxide; P ET,O 2 , end-tidal partial pressure of oxygen; S aO 2 , oxygen saturation; SBP, systolic blood pressure; and SV, stroke volume (n = 10). * Significant main effect for intervention (normoxia versus hypoxia), P ࣘ 0.04. † Significant main effect for conditions (P ET,O 2 75 versus 50 mmHg), P ࣘ 0.04. ‡ Significant interaction between intervention and conditions, P ࣘ 0.02.
Results
Effect of hypoxia on cardiorespiratory variables
According to the study design, a significant interaction between the experimental intervention (normoxia versus hypoxia) and experimental conditions (P ET,O 2 75 mmHg trial versus P ET,O 2 50 mmHg trial) was evident for P ET,O 2 (P < 0.01). No difference in baseline (normoxia) P ET,O 2 was evident between experimental conditions; however, as desired, P ET,O 2 was lower during hypoxic exposure in the P ET,O 2 50 mmHg (50 ± 3 mmHg) versus the P ET,O 2 75 mmHg trial (74 ± 2 mmHg; P < 0.01; Table 1 ). There were no differences in P ET,CO 2 during the experimental intervention or conditions (Table 1) . A significant interaction between the experimental intervention and experimental conditions was evident for ventilation (P < 0.01; Table 1 ). Compared with normoxia, ventilation was increased during exposure to P ET,O 2 75 mmHg (+3.1 ± 3.5%; P = 0.01) and P ET,O 2 50 mmHg (+10.0 ± 5.8%; P < 0.01); the increase in ventilation was greater during exposure to P ET,O 2 50 mmHg (P < 0.01). Likewise, a significant interaction between the experimental intervention and experimental conditions was evident for arterial oxygen saturation (S aO 2 ; P = 0.001; Table 1 ). Compared with normoxia, the reductions in S aO 2 were greater at P ET,O 2 50 mmHg compared with 75 mmHg (-15 ± 3 versus −5 ± 2%; P < 0.01).
A main effect for the experimental intervention was evident for mean arterial blood pressure (MAP) independent of hypoxic stimulus; compared with normoxia, MAP increased in both hypoxic trials by 6 ± 2 mmHg (P = 0.001; Table 1), respectively. An interaction between experimental intervention and experimental conditions was evident for HR (P = 0.01) and CO (P = 0.03; Table 1 ). The increase in HR was greater (6 ± 4 beats min −1 ; P < 0.01; Table 1) in the P ET,O 2 50 mmHg trial compared with the P ET,O 2 75 mmHg trial. Likewise, the increase in CO was greater in the P ET,O 2 50 mmHg trial (0.6 ± 0.7 l min −1 ; P = 0.03; Table 1) . No difference was evident in the SV response during exposure to hypoxia (n = 10).
Effect of hypoxia on brachial artery baseline measures
A significant interaction between the experimental intervention (normoxia versus hypoxia) and experimental conditions (P ET,O 2 75 mmHg trial versus P ET,O 2 50 mmHg trial) was evident for baseline brachial arterial diameter (P = 0.01). After exposure to P ET,O 2 50 mmHg, arterial diameter increased by 0.02 ± 0.02 cm (relative, 4%; P = 0.01). In contrast, no diameter changes were evident during exposure to P ET,O 2 75 mmHg (P = 0.80; Table 2 ).
Compared with normoxia, independent of the level of hypoxic stimulus, significant main effects were evident for reductions in baseline peak blood velocity [−3.6 ± 2.9 cm s −1 (relative, ß−42%); P < 0.01], baseline peak blood flow [−13.2 ± 9.3 ml min −1 (relative, ß−39%); P = 0.01], baseline mean SR [−37 ± 12 s (relative, ß−43%); P < 0.01] and baseline anterograde SR [−24 ± 7 s (relative, ß −21%); P = 0.01], and an increase in baseline retrograde SR [+13 ± 5 s (relative, ß +48%); P = 0.01; Table 2 and Fig. 1] . A significant interaction between intervention (normoxia versus hypoxia) and experimental conditions (P ET,O 2 75 mmHg trial versus P ET,O 2 50 mmHg trial) was evident for baseline retrograde SR (P < 0.01); the increase in retrograde SR was greater during exposure to P ET,O 2 50 mmHg (+18 ± 9 s) than N. C. S. Lewis and others Values are expressed as means ± SD. * Significant main effect for intervention (normoxia versus hypoxia), P < 0.01. † Significant main effect for hypoxic conditions (75 versus 50 mmHg), P = 0.01. ‡ Significant interaction between intervention and conditions, P < 0.001.
during exposure to P ET,O 2 75 mmHg (+8 ± 2 s; P = 0.03; Fig. 1 ).
Effect of hypoxia on brachial artery FMD (n = 12)
Compared with normoxia, FMD was significantly reduced during exposure to P ET,O 2 75 mmHg [−1.1 ± 1.1% (relative, ß −17%); P = 0.005] and P ET,O 2 50 mmHg [−3.1 ± 1.7% (relative 45%); P < 0.01]; the decline in FMD was greater during exposure to P ET,O 2 50 mmHg by 2 ± 1% (relative, 63%; P < 0.01; see Fig. 2A ). A significant main effect for intervention was evident for SR AUC (P = 0.01); compared with normoxia, SR AUC (25,855 ± 9699 a.u) was reduced during hypoxic exposure (19,441 ± 10,386 a.u) independent of hypoxic stimulus (Table 2) . After allometric scaling of FMD and accounting for the decline in SR AUC as a covariate, a significant interaction between experimental intervention and experimental conditions was evident (P < 0.01). Compared with normoxia, FMD was significantly reduced during exposure to P ET,O 2 75 mmHg [−0.5% (relative, −8%)], but the decline after the 30 min exposure to P ET,O 2 50 mmHg was greater [−2.1% (relative, ß−32%); Fig. 2B ].
Effect of hypoxia on brachial artery GTN (n = 8; Table 3)
One-way ANOVA revealed that GTN-induced dilatation was reduced during hypoxic exposure (P = 0.01; Fig. 3A (relative, 14%; P = 0.06; Fig. 3 Table 3 ).
Normoxic time-control study (n = 10)
Baseline MAP, HR and percentage S aO 2 were 80 ± 6 mmHg, 56 ± 8 beats min −1 and 98 ± 1%, respectively. No significant difference in baseline diameter was evident after 30 min of supine rest (Table 4) . Compared with baseline (pre-FMD 1), however, reductions in baseline peak blood flow velocity [−5.8 ± 1.2 cm s −1 (relative, ß36%); P = 0.01] and peak blood flow [−0.98 ± 0.32 ml min −1 (relative, ß37%); P < 0.01] were evident after 30 min of supine rest (Table 4) . Reductions in baseline mean SR [ß−37 ± 8 s (relative, ß−34%); P < 0.04] and baseline anterograde SR [−32 ± 8 s (relative, ß−27%); P = 0.06] were evident following FMD 1 and 30 min of supine rest, but retrograde SR was not significantly changed (P = 0.19; Table 4 ). Compared with FMD 1, FMD was significantly reduced after 30 min of supine rest by −0.62 ± 0.28% (relative, ß−8.4%; P = 0.02). No significant difference in FMD SR AUC was evident between the two FMDs (P = 0.13; Table 4 ). After allometric scaling of FMD, where baseline diameter and SR AUC were considered as covariates, the decline in FMD after 30 min of supine rest was still evident (P = 0.05; Fig. 4 ). 
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Discussion
The primary aim of the main study was to examine the acute effects (<60 min) of mild (P ET,O 2 75 mmHg; ß2000 m) and moderate (P ET,O 2 50 mmHg; ß5000 m) isocapnic normobaric hypoxic stimuli on the vascular dilator system via the assessment of FMD and GTN-induced dilatation in the brachial artery. The new findings were as follows. First, compared with normoxia, FMD and GTN-induced dilatation were reduced during moderate hypoxia and, to a lesser extent, after mild hypoxic exposure. Second, FMD SR AUC was reduced during both moderate and mild hypoxic conditions; however, when the decline in FMD was corrected for the decline in SR AUC , the decline in FMD with mild and moderate hypoxia were attenuated. Third, after exposure to both mild and moderate hypoxia there was a decline in baseline blood flow and anterograde SR, and an increase in retrograde SR. The increase in retrograde SR was greater during moderate hypoxia. The main findings of the normoxic time-control study were that baseline blood flow and FMD were reduced after 30 min of supine normoxic rest. Based on these findings, the following discussion outlines putative mechanisms that are likely to underpin hypoxia-induced declines in vascular function, including: (i) hypoxia-induced decline in FMD SR AUC ; (ii) methodological considerations of repetitive FMD testing; (iii) alteration in blood flow and SR patterns; and (iv) an attenuated capacity for smooth muscle relaxation, independent of endothelial release of vasoactive peptides.
Acute hypoxia and FMD
The initial finding of this study revealed an acute decline in FMD after 30 min of isocapnic hypoxia, which appears to be dependent on the severity of the hypoxic stimulus. The relative FMD was reduced by ß17 and ß45% during 30 min of mild (P ET,O 2 75 mmHg, S aO 2 93%) and moderate (P ET,O 2 50 mmHg, S aO 2 83%) hypoxia, respectively. The SR AUC component of the FMD provides an estimation of the shear stress stimulus created upon cuff release, which ultimately provokes the production and release of NO from the endothelium. In both hypoxic trials, FMD SR AUC decreased by ß25%, a finding which was not evident in our normoxic time-control trial. Although not statistically significant, SR AUC has previously been reported to be reduced by ß21% after 60 min of hypoxia and appears to recover to pre-hypoxic levels after ß6 h of hypoxic exposure (Lewis et al. 2014 ). When we accounted for the decline in FMD SR AUC in our covariate analyses, we found the relative decline in FMD with mild hypoxia (−17 to −8%) and moderate hypoxia (−45 to −32%) was attenuated by ß9%. These results suggest that the decline in FMD with hypoxia is partly attributable to a decline in FMD SR AUC . Although the mechanism(s) influencing the decline in FMD SR AUC with acute hypoxia are unknown, it is possible that vascular sympathetic constraint during the hypoxic (Weisbrod et al. 2001) exposure might have hindered the ischaemic response to FMD cuff occlusion and resulted in a lower reactive hyperaemic response on cuff release. Nevertheless, as discussed next, other mechanism(s) also appear to affect the decline in FMD with moderate hypoxia. As a result of recent studies reporting that sitting rest (e.g. 2-6 h; Thosar et al. 2014; Restaino et al. 2015) can alter brachial shear patterns, a strength of our study was that we conducted a normoxic time-control trial to examine the effect of supine lying/inactivity on repetitive FMD testing. Our data indicate that after 30 min of supine rest, FMD is reduced by 8% (relative). This finding contradicts the finding by Harris et al. (2006) , who reported a 5% (relative) non-significant (P = 0.35) increase in FMD after 30 min of supine rest (Harris et al. 2006) . However, owing to methodical limitations, comparison between our studies is difficult. Although not mentioned in the recent FMD guidelines (Thijssen et al. 2011) , the original International Brachial Artery Reactivity Task Force (Corretti et al. 2002) stated that at least 10 min of supine rest is needed after reactive hyperaemia before another assessment is conducted. More recently, it was reported that repeated measures of FMD in the brachial artery may be taken after a minimum of 5 min or as soon as the vessel has returned to its baseline diameter (Barton et al. 2011) . In light of these studies, 30 min of supine rest between FMD assessment in the present studies should have been a conservative recovery period, especially given that baseline arterial diameter was unchanged in the time-control study and during exposure to mild hypoxia. Arterial diameter was larger during exposure to moderate hypoxia; however, this was probably attributable to the effect of moderate hypoxia and has been accounted for in our interpretations of the data (allometric scaling).
Independent of the severity of hypoxic exposure, pre-FMD baseline blood flow and anterograde SR were reduced by ß39 and 21%, respectively. Declines in brachial 
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artery blood flow (−11%) and blood flow velocity (−2%) have previously been reported after 10 min of moderate hypoxia (F I,O 2 0.12; Iwamoto et al. 2015) . Given that a similar decline in blood flow and anterograde SR was also evident after 30 min of supine rest in our normoxic time-control trial (ß27-35%), it is likely that these changes in blood flow haemodynamics are not isolated to hypoxia alone. There is evidence to suggest that prolonged sitting/inactivity for a period >60 min is associated with a decline in brachial artery blood flow (Restaino et al. 2015) ; however, an 'acute' inactivity period of 6 h did not negatively impact FMD in the brachial artery despite a decline in SR AUC (Restaino et al. 2015) .
Although it was not significant, SR AUC was reduced by 11% in the normoxic control trial after 30 min of rest. Whether changes in baseline blood flow haemodynamics and alterations in SR AUC after 30 min of rest negatively impact FMD warrant further investigation and could have contributed to the decline seen in FMD during hypoxic exposure. The methodological implications of these findings merit consideration in related experimental designs and further research. During exposure to both mild and moderate hypoxia, there was a significant increase in baseline retrograde SR (ß48%); this response was not evident in our normoxic control trial, and therefore, we are confident that this response is mediated by hypoxia. This finding is supported by others who have reported an increase in retrograde SR (>39%) after 10 min of hypoxia (F I,O 2 0.12; Iwamoto et al. 2015; Katayama et al. 2016) . Although hypoxia causes net vasodilatation (Heistad & Wheeler, 1970) , sympathetic excitation within 5-10 min of isocapnic hypoxia (S aO 2 85%) exposure has been shown to mask the vasodilatory effects of hypoxia in the resistant vessels of the forearm (Weisbrod et al. 2001 (Weisbrod et al. , 2004 . Additionally, acute excitation and elimination of sympathetic nerve activity on forearm vascular resistance has been shown respectively to increase and reduce baseline retrograde SR in the brachial artery (Thijssen et al. 2009; Padilla et al. 2010 Padilla et al. , 2014 Casey et al. 2012 ). Therefore, it is possible that heightened sympathetic vasoconstrictor activity with acute hypoxia (Dinenno et al. 2003) and, subsequently, constraint of hypoxic vasodilatation in the forearm (Weisbrod et al. 2001) could have increased downstream resistance vessel tone and altered SR blood flow patterns.
Additionally, the increase in retrograde SR was significantly larger during exposure to moderate hypoxia than to mild hypoxia. Acute and progressive increases in baseline retrograde SR in the brachial artery have been shown to elicit a dose-dependent impairment in brachial FMD (Thijssen et al. 2009 ). Furthermore, graded reductions in hypoxia have been shown to elicit a graded increase in muscle sympathetic nerve activity (MSNA; Rowell et al. 1989) , and graded increase in MSNA has been associated with an incremental increase in retrograde (Padilla et al. 2010 ). Therefore, it is possible that during exposure to moderate hypoxia there was a larger increase in SNA and, consequently, a larger increase in retrograde SR, leading a greater reduction in FMD in these hypoxic conditions; this concept warrants future investigation.
Impaired vascular smooth muscle relaxation
The GTN-induced dilatation in the present study was reduced by (relative) ß13 and ß22% during 60 min of mild and moderate hypoxia, respectively. We have previously reported a decline (relative, ß14%) in GTN-induced dilatation after 3 days at 5050 m (Lewis et al. 2014) ; however, as far as we are aware, this is the first report to examine the acute effects of hypoxia on GTN-induced vasodilatation. As the assessment of GTN-induced dilatation represents vascular smooth muscle cell sensitivity to NO (Corretti et al. 2002; Maruhashi et al. 2013) , the findings of the present study support the notion of impairment in vascular smooth muscle function during acute hypoxic exposure (Lewis et al. 2014) . This graded reduction in GTN-induced dilatation during progressive exposure to hypoxia contributed to the impairment in FMD.
The acute decline in FMD after 60 min of normobaric hypoxia has previously been shown to be reversed, in part, after an α 1 -adrenoreceptor blockade, suggesting that sympathoexcitation is one of the mechanisms by which FMD is impaired after acute hypoxic exposure (Weisbrod et al. 2004; Lewis et al. 2014) . Although the effect of hypoxia-induced sympathoexcitation on the acute impairment in GTN-induced dilatation has not been reported, it is likely to be a key mechanism for reductions in FMD (Saito et al. 1988; Rowell et al. 1989) , i.e. via increasing vascular smooth muscle tone and impairing vascular smooth muscle cell ability to relax in response to NO. Previous work has reported a ß20% increase in MSNA after 5 min of isocapnic hypoxia (F I,O 2 0.10; S aO 2 82%; Somers et al. 1988) . Moreover, Rowell et al. (1989) reported an inverse relationship between graded reductions in F I,O 2 and elevations in MSNA. For example, after 20 min of hypoxia at F I,O 2 0.12 and 0.10, MSNA was elevated by ß90 and 250%, respectively (Rowell et al. 1989) . Therefore, given that hypoxia-induced elevation in SNA seems to be dependent on the severity of the hypoxic stimulus (Rowell et al. 1989) , this mechanism could explain the progressive declines in GTN-induced dilatation and, subsequently, FMD with hypoxia in the present study. Future studies combining MSNA measurement with and without SNA blockade are needed to test this hypothesis clearly.
When we corrected our assessments of FMD with the changes in GTN-induced dilatation with hypoxia, we found that FMD%:GTN% was decreased by ß11 and ß35% from normoxic baseline during exposure to mild and moderate hypoxia, respectively. The FMD:GTN ratio represents shear stress-mediated endothelial release of NO, independent of the smooth muscle relaxation capacity global NO-dependent vasodilator function (Spence et al. 2013; Lewis et al. 2014) ; therefore, after 30 min of exposure to hypoxia, it appears that the decline in FMD is attributable, in part, to a decline in endothelial SR-mediated function in addition to a decline in vascular smooth muscle function. The contribution of endothelial SR-mediated impairment appears to be larger during exposure to moderate hypoxia.
Conclusion
In summary, after both mild and moderate levels of hypoxia, there was a graded impairment in FMD, which appears to be influenced by a decline in FMD SR AUC , and an incremental increase in retrograde SR and incremental decline in smooth muscle vasodilator capacity (impaired GTN-induced dilatation). Our findings from the normoxic control study suggest that the decline in FMD during acute hypoxia also appears to be influenced by 30 min of supine rest/inactivity in between FMD assessments. The mechanism(s) underpinning this reduction with supine rest and related methodological implications deserve further investigation.
